Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli

被引:82
作者
McShea, A
Zelasko, DA
Gerst, JL
Smith, MA
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Fred Hutchinson Canc Res Ctr, Program Canc Biol, Seattle, WA 98109 USA
关键词
Alzheimer's disease; cell cycle; Grb2; signal transduction; SOS-1;
D O I
10.1016/S0006-8993(98)01135-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Hippocampal and select cortical neuronal populations in Alzheimer's disease exhibit phenotypic changes characteristic of cells re-entering the cell division cycle. Therefore, in this study, we investigated whether components, known to trigger cellular proliferation and differentiation, upstream of the ras/mitogen-activated kinase pathway, could contribute to the activation of a signal transduction cascade in Alzheimer's disease. We found that proteins implicated in signal transduction from cell surface receptors via the ras pathway, namely Grb2 and SOS-1, were altered in cases of Alzheimer's disease in comparison to age-matched controls. SOS is increased in susceptible pyramidal neurons, while Grb2 shows more subtle alterations in subcellular distribution. importantly, both SOS-1 and Grb2 show considerable overlap with early cytoskeletal abnormalities suggesting that the alteration in signal transduction molecules is a concurrent, if not preceding, event in the pathogenesis of Alzheimer's disease. Taken together with the cell cycle abnormalities previously reported, these findings suggest that a signal derived from the cell surface contributes to a stimulus for neurons in Alzheimer's disease to re-enter the cell cycle. (C) 1999 Elsevier Science B.V. An rights reserved.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 46 条
[21]  
McShea A, 1997, AM J PATHOL, V150, P1933
[22]  
MCSHEA A, IN PRESS MED HYPOTHE
[23]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[24]   Cell cycle markers in the hippocampus in Alzheimer's disease [J].
Nagy, Z ;
Esiri, MM ;
Cato, AM ;
Smith, AD .
ACTA NEUROPATHOLOGICA, 1997, 94 (01) :6-15
[25]   Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions [J].
Nagy, Z ;
Esiri, MM ;
Smith, AD .
ACTA NEUROPATHOLOGICA, 1997, 93 (03) :294-300
[26]   NGF AND THE TREATMENT OF ALZHEIMERS-DISEASE [J].
OLSON, L .
EXPERIMENTAL NEUROLOGY, 1993, 124 (01) :5-15
[27]  
Park DS, 1997, J NEUROSCI, V17, P8975
[28]  
Rao GN, 1996, ONCOGENE, V13, P713
[29]  
Sayre LM, 1997, J NEUROCHEM, V68, P2092
[30]  
Shirvan A, 1997, J NEUROCHEM, V69, P539